Seung S. Lee

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 211 publications

Molecular profiling of pancreatic acinar cell carcinoma and amphicrine-like carcinoma: high frequency of homologous recombination deficiency and molecular heterogeneity.

Molecular profiling of pancreatic acinar cell carcinoma and amphicrine-like carcinoma: high frequency of homologous recombination deficiency and molecular heterogeneity.

Journal: Histopathology

Published: August 06, 2026

Shortened preparative fasting before contrast-enhanced CT and acute adverse drug reactions: A real-world observational study of 242,435 examinations.

Shortened preparative fasting before contrast-enhanced CT and acute adverse drug reactions: A real-world observational study of 242,435 examinations.

Journal: European journal of radiology

Published: June 30, 2026

Prognostic Implications of CT- and MRI-Based LI-RADS Category M Features in Intrahepatic Cholangiocarcinoma: An Intraindividual Comparison.

Prognostic Implications of CT- and MRI-Based LI-RADS Category M Features in Intrahepatic Cholangiocarcinoma: An Intraindividual Comparison.

Journal: Korean journal of radiology

Published: April 21, 2026

Gadoxetate-enhanced MRI Transitional Phase Parenchymal Signal: Effect on Washout and LI-RADS Diagnostic Performance for Hepatocellular Carcinoma.

Gadoxetate-enhanced MRI Transitional Phase Parenchymal Signal: Effect on Washout and LI-RADS Diagnostic Performance for Hepatocellular Carcinoma.

Journal: Radiology

Published: March 31, 2026

Prognostic Significance of Intraindividual CT and MRI LI-RADS Agreement and Discordance in Hepatocellular Carcinoma.

Prognostic Significance of Intraindividual CT and MRI LI-RADS Agreement and Discordance in Hepatocellular Carcinoma.

Journal: Radiology. Imaging cancer

Published: March 27, 2026

MRI-based Risk Scoring System to Predict Early Recurrence after Resection of Solitary Hepatocellular Carcinoma 5 cm or Smaller.

MRI-based Risk Scoring System to Predict Early Recurrence after Resection of Solitary Hepatocellular Carcinoma 5 cm or Smaller.

Journal: Radiology

Published: March 10, 2026

Erratum for: Establishing CT-derived Normative Liver and Spleen Volumes for Children: Validation in Regional and International Datasets.

Erratum for: Establishing CT-derived Normative Liver and Spleen Volumes for Children: Validation in Regional and International Datasets.

Journal: Radiology

Published: February 24, 2026

Intraductal Papillary Squamous Neoplasm (IPSN) of the Pancreas: Histological and Molecular Characterization of a Novel and Distinct Intraductal Cancer Precursor.

Intraductal Papillary Squamous Neoplasm (IPSN) of the Pancreas: Histological and Molecular Characterization of a Novel and Distinct Intraductal Cancer Precursor.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Published: February 08, 2026

Establishing CT-derived Normative Liver and Spleen Volumes for Children: Validation in Regional and International Datasets.

Establishing CT-derived Normative Liver and Spleen Volumes for Children: Validation in Regional and International Datasets.

Journal: Radiology

Published: January 27, 2026

Transabdominal ultrasonography as an alternative modality for pancreatic cyst surveillance: potentials and limitations.

Transabdominal ultrasonography as an alternative modality for pancreatic cyst surveillance: potentials and limitations.

Journal: Ultrasonography (Seoul, Korea)

Published: January 23, 2026

MRI-based prediction of very early recurrence within 1 year after resection of HCC: An international cohort study.

MRI-based prediction of very early recurrence within 1 year after resection of HCC: An international cohort study.

Journal: Journal of hepatology

Published: December 09, 2025

Radiologic Response Assessment With RECIST 1.1 and mRECIST in Patients With Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab.

Radiologic Response Assessment With RECIST 1.1 and mRECIST in Patients With Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab.

Journal: Korean journal of radiology

Published: December 04, 2025

Showing 1-12 of 211

Last Updated: 09/26/2026